Qlife Holding AB (OSTO:QLIFE) FCF Margin % : -23,426.67% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Qlife Holding AB's Free Cash Flow for the three months ended in Sep. 2023 was kr-10.54 Mil. Qlife Holding AB's Revenue for the three months ended in Sep. 2023 was kr0.05 Mil. Therefore, Qlife Holding AB's FCF Margin % for the quarter that ended in Sep. 2023 was -23,426.67%.

As of today, Qlife Holding AB's current FCF Yield % is -277.28%.

The historical rank and industry rank for Qlife Holding AB's FCF Margin % or its related term are showing as below:

OSTO:QLIFE' s FCF Margin % Range Over the Past 10 Years
Min: -1549.62 Med: -210.4 Max: -134.86
Current: -1549.62

During the past 4 years, the highest FCF Margin % of Qlife Holding AB was -134.86%. The lowest was -1549.62%. And the median was -210.40%.

OSTO:QLIFE's FCF Margin % is ranked worse than
93.99% of 832 companies
in the Medical Devices & Instruments industry
Industry Median: -7.45 vs OSTO:QLIFE: -1549.62

Qlife Holding AB FCF Margin % Historical Data

The historical data trend for Qlife Holding AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB FCF Margin % Chart

Qlife Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Margin %

-210.40

-134.86

-503.93

Qlife Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Margin %	Get a 7-Day Free Trial														-3,872.75	3,091.61	-14,194.31	-56,919.57	-23,426.67

Competitive Comparison of Qlife Holding AB's FCF Margin %

For the Medical Devices subindustry, Qlife Holding AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qlife Holding AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's FCF Margin % falls into.

Qlife Holding AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Qlife Holding AB's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-90.673	/	17.993
	=	-503.93 %

Qlife Holding AB's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-10.542	/	0.045
	=	-23,426.67 %

Qlife Holding AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qlife Holding AB (OSTO:QLIFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

4HG:Germany

Address

Redaregatan 48, Helsingborg, SWE, SE-252 36

Website

https://www.qlifeholding.com

Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines